XBiotech Stock
XBiotech Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Sushma Shivaswamy
- Employees
- 87
- Market cap
- $65 M
- IPO
- 15/04/2015
XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is…
XBiotech stock: price history
1D
-1.9%
1W
-7.4%
1M
-1.4%
6M
-13.8%
YTD
-11.3%
1Y
-14.9%
2Y
-72.5%
5Y
-84.0%
10Y
-84.1%
Next earnings date
Next earnings date
No date known
Volatility around earnings
~32% weaker price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about XBiotech
Analyst assessment of XBiotech
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 07/04/2020
XBiotech stock metrics
P/E
-1.43
P/B
0.5
EV/EBITDA
1.08
RETURN ON EQUITY
-5.2%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
63.1%
FLOAT SHARES
19,247,678
AVG. DAILY VOLUME (30D)
42,716
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about XBiotech stock
What does XBiotech do?
XBiotech Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Sushma Shivaswamy, the company employs around 87 people.
The IPO was on 15/04/2015; the stock trades on NASDAQ under the ticker XBIT.
What do analysts say about XBiotech stock?
3 analysts rate the stock, the consensus is Buy (as of 07/04/2020).
This is an external assessment, not a statement by Market Jury.
When does XBiotech report next?
Around past earnings, price swings were roughly -32% stronger than usual.
Does XBiotech pay a dividend?
Yes. The last dividend was US$2.50 per share, ex-date 15/07/2021, paid on 23/07/2021.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to XBiotech?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get XBiotech stock analyzed?
Clicking "Analyze stock" lets five strategies assess XBiotech against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.